SLC22A12 gene

Known as: OAT4L, URATE TRANSPORTER 1, SOLUTE CARRIER FAMILY 22 (URATE TRANSPORTER), MEMBER 12 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Astilbin is a flavonoid compound derived from the rhizome of Smilax china L. The effects and possible molecular mechanisms of… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Review
2012
Review
2012
In addition to its role as a metabolic waste product, uric acid has been proposed to be an important molecule with multiple… (More)
Is this relevant?
2012
2012
BACKGROUND/AIMS Hyperuricemia is associated with obesity and the metabolic syndrome. URAT1 is a urate transporter, and we tested… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
Is this relevant?
2011
2011
AIM Hyperuricaemia is a significant factor in a variety of diseases, including gout and cardiovascular diseases. The kidney plays… (More)
Is this relevant?
2010
2010
OBJECTIVE To examine the effects of fenofibrate, an antilipotropic drug, on uric acid metabolism in healthy male subjects and on… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2007
2007
OBJECTIVE Primary renal hypouricaemia is a hereditary clinical disorder characterized by increased renal urate clearance due to… (More)
Is this relevant?
2006
2006
OBJECTIVE To analyse the SLC22A12 (URAT1) gene in primary gout patients, first-grade relatives and healthy controls and the… (More)
Is this relevant?
Review
2005
Review
2005
Urate is the major inert end product of purine degradation in higher primates in contrast to most other mammals because of the… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Renal hypouricemia is an inherited and heterogeneous disorder characterized by increased urate clearance (CUA). The authors… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2002
Highly Cited
2002
We thank the patients for contributing to this study; Y. Terado for discussions on immunohistochemistry, K. Tachampa and J. Y… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
Is this relevant?